BioCorRx (BICX) Beginning Cash Balance (2012 - 2026)

BioCorRx has disclosed Beginning Cash Balance across 4 years of filings, most recently posting $5000.0 for Q1 2026.

• Beginning Cash Balance for Q1 2026 came in at $5000.0, down 28.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $523700.0 (up 2809.44% YoY), and the FY2025 annual result was $525700.0, up 4679.09% from the prior year.
• Beginning Cash Balance came in at $5000.0 for Q1 2026 at BioCorRx, down from $518700.0 in the prior quarter.
• In the past five years, Beginning Cash Balance ranged from a high of $518700.0 in Q4 2025 to a low of $2000.0 in Q4 2024.
• The 3-year median for Beginning Cash Balance is $7000.0 (2025), against an average of $108340.0.
• Across the five-year window, Beginning Cash Balance jumped 25835.0% in 2025 and retreated 28.57% in 2026, its largest moves.
• BioCorRx's Beginning Cash Balance stood at $2000.0 in 2024, then surged by 25835.0% to $518700.0 in 2025, then plunged by 99.04% to $5000.0 in 2026.
• The last three Beginning Cash Balance figures came in at $5000.0 (Q1 2026), $518700.0 (Q4 2025), and $7000.0 (Q1 2025), per Business Quant data.